Perkins Coie Trust Co - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.64 and the average weighting 0.4%.

Quarter-by-quarter ownership
Perkins Coie Trust Co ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$53
-57.3%
1780.0%0.00%
Q2 2023$124
-21.5%
1780.0%0.00%
Q1 2023$158
-24.0%
1780.0%0.00%
Q4 2022$208
-79.2%
1780.0%0.00%
Q3 2022$1,0000.0%1780.0%0.00%
Q2 2022$1,0000.0%1780.0%0.00%
Q1 2022$1,0000.0%1780.0%0.00%
Q4 2021$1,0000.0%1780.0%0.00%
Q3 2021$1,000
-50.0%
1780.0%0.00%
-100.0%
Q2 2021$2,0000.0%1780.0%0.00%0.0%
Q1 2021$2,0000.0%1780.0%0.00%0.0%
Q4 2020$2,000
+100.0%
1780.0%0.00%
Q3 2020$1,000
-50.0%
1780.0%0.00%
-100.0%
Q2 2020$2,000
+100.0%
1780.0%0.00%0.0%
Q1 2020$1,000
-66.7%
1780.0%0.00%0.0%
Q4 2019$3,000
+50.0%
1780.0%0.00%0.0%
Q3 2019$2,0000.0%1780.0%0.00%0.0%
Q2 2019$2,0000.0%1780.0%0.00%0.0%
Q1 2019$2,0000.0%1780.0%0.00%0.0%
Q4 2018$2,0000.0%1780.0%0.00%0.0%
Q3 2018$2,0000.0%1780.0%0.00%0.0%
Q2 2018$2,0000.0%1780.0%0.00%0.0%
Q1 2018$2,0000.0%1780.0%0.00%0.0%
Q4 2017$2,0000.0%1780.0%0.00%0.0%
Q3 2017$2,000
+100.0%
1780.0%0.00%0.0%
Q2 2017$1,000
-50.0%
1780.0%0.00%0.0%
Q1 2017$2,0001780.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$14,118,0003.56%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$12,637,0002.99%
SPHERA FUNDS MANAGEMENT LTD. 385,301$3,044,0000.52%
Boxer Capital, LLC 138,331$1,093,0000.26%
DAFNA Capital Management LLC 35,977$284,0000.20%
SABBY MANAGEMENT, LLC 223,100$1,762,0000.12%
Hikari Power Ltd 60,992$482,0000.06%
Perceptive Advisors 157,679$1,245,0000.06%
Lombard Odier Asset Management (USA) Corp 90,000$711,0000.06%
TFS CAPITAL LLC 12,128$96,0000.04%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders